CAMPBELL, CA --(Marketwired - February 28, 2017) - VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the
fourth quarter of 2016 after the NASDAQ Market closes on Wednesday, March 8, 2017. The company will conduct a conference call and
an audio webcast at 4:30 pm EST the same day.
Date: March 8, 2017
Time: 4:30 PM EST
Listen via Internet: http://ir.vivus.com/
Webcast Link: http://edge.media-server.com/m/p/wqto3kub
Dial in (Toll-Free): (877) 359-2916
Dial in (International): (224) 357-2386
Audience Passcode: 6605 7048
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet
medical needs in human health. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform
Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast,"
"estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There
are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking
statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the
risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2015 as filed on March 9, 2016 and as amended by the
Form 10-K/A filed on April 22, 2016, and periodic reports filed with the Securities and Exchange Commission.